Published in Anal Biochem on August 01, 1970
Quantitative determination and location of newly synthesized virus-specific ribonucleic acid in chicken cells infected with Rous sarcoma virus. J Virol (1973) 2.45
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol (1995) 2.20
Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol (1997) 1.88
Characterization of the mRNA of influenza virus. J Virol (1975) 1.71
In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product. J Virol (1979) 1.71
A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol (1997) 1.63
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Extensive in vitro transcription of rous sarcoma virus RNA by avian myeloblastosis virus DNA polymerase and concurrent activation of the associated RNase H. J Virol (1977) 1.52
The nucleic acid of Sendai virus and ribonucleic acid synthesis in cells infected by Sendai virus. J Gen Virol (1968) 1.36
The sedimentation of influenza virus and its RNA in sucrose density gradients. J Gen Virol (1968) 1.36
New procedure for the direct analysis of in vitro reverse transcription of Rous sarcoma virus RNA. J Virol (1977) 1.29
Mouse cells expressing human intercellular adhesion molecule-1 are susceptible to infection by coxsackievirus A21. J Virol (1997) 1.23
Participation of DNA-dependent RNA polymerase II in replication of influenza viruses. Nature (1977) 1.22
Ribonucleic acid polymerase induced in cells infected with Sendai virus. J Virol (1970) 1.22
Molecular weight of RNA subunits of Rous sarcoma virus determined by electron microscopy. J Virol (1975) 1.20
Analysis of Rous sarcoma virus (RSV) RNA structure by means of specific nucleases. Virology (1978) 1.20
Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection. J Clin Microbiol (1989) 1.19
The influenza virus genome and its replication. Br Med Bull (1979) 1.19
Nucleic acid of influenza virus. Nature (1966) 1.18
Characterization of the ribonucleic acid of fowl plague virus. Arch Gesamte Virusforsch (1973) 1.15
Genetic recombination between two strains of fowl plague virus: construction of genetic maps. Virology (1979) 1.15
In vitro product of a ribonucleic acid polymerase induced by influenza virus. J Virol (1970) 1.12
Characterization of recombinant Eschericha coli 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase: analysis of enzymatic activity and substrate specificity. Biochem Biophys Res Commun (1996) 1.07
Influenza A antigens on human lymphocytes in vitro and probably in vivo. Nature (1976) 1.06
Analysis of the secondary and tertiary structures of Rous sarcoma virus RNA. Nucleic Acids Res (1980) 1.06
Massive heat-shock polypeptide synthesis in late chicken embryos: convenient system for study of protein synthesis in highly differentiated organisms. Mol Cell Biol (1982) 1.00
Method for assigning temperature-sensitive mutations of influenza viruses to individual segments of the genome. Virology (1977) 1.00
Multiplication of influenza virus in the presence of cordycepin, an inhibitor of cellular RNA synthesis. Nat New Biol (1973) 0.99
The development of Akabane virus-induced congenital abnormalities in cattle. Vet Rec (1988) 0.97
Characterization of the genomic RNA from a Rous sarcoma virus mutant temperature sensitive for cell transformation. Nucleic Acids Res (1979) 0.96
Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells. Virology (1997) 0.93
Temperature-sensitive mutants of fowl plague virus: isolation and genetic characterization. Virology (1979) 0.92
Characterization of human parainfluenza viruses. I. The structural proteins of parainfluenza virus 2 and their synthesis in infected cells. J Gen Virol (1983) 0.91
An impending epidemic of bovine congenital deformities. Aust Vet J (1983) 0.89
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. J Immunol (1998) 0.88
Hybridization studies of the relationship between influenza virus RNA and cellular DNA. Virology (1976) 0.87
A model structure for Rous sarcoma virus genomic RNA and its implication for various functions of the viral RNA. Mol Biol Rep (1981) 0.87
A study of respiratory infections in a healthy adult population during the 1987 Australian winter. Fam Pract (1993) 0.86
Single and divided doses of penbutolol. Clin Pharmacol Ther (1979) 0.85
Synthesis of ribonuclease-resistant ribonucleic acid by fowl-plague-virus-induced ribonucleic acid polymerase. Biochem J (1969) 0.85
Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. J Gen Virol (2000) 0.83
Immunization against influenza by the ocular route. Vaccine (1985) 0.82
Detecting the cause of Lyme disease in Australia. Med J Aust (1991) 0.82
New procedure for isolation of Rous sarcoma virus-specific RNA from infected cells. J Virol (1979) 0.80
Simultaneous determination of pregnanediol and pregnanolone in urinary extracts by gas chromatography. Clin Chem (1968) 0.79
A simple procedure for the analysis of the structural proteins of influenza and parainfluenza viruses involving adsorption to erythrocytes. J Virol Methods (1984) 0.78
The topography of RNA synthesis in cells infected with fowl plague virus. J Gen Virol (1974) 0.78
Western blot analysis of antibody responses to influenza virion proteins. Immunol Cell Biol (1992) 0.78
A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers. Epidemiol Infect (1988) 0.78
Characterization of the src gene of a Rous sarcoma virus mutant temperature-sensitive for cell transformation. Cold Spring Harb Symp Quant Biol (1980) 0.76
The effects of UK2054 on the multiplication of influenza viruses. J Hyg (Lond) (1970) 0.75
Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application. S Afr Med J (1978) 0.75
Comparison of four methods of determining urinary pregnanediol. Anal Chem (1966) 0.75
Immunization against influenza by the ocular route. Brief report. Arch Virol (1983) 0.75
Determination of the molecular weight of the RNA subunits of Rous sarcoma virus by electron microscopy. Cold Spring Harb Symp Quant Biol (1975) 0.75
The role of the cell nucleus in the production of influenza viruses. J Med Microbiol (1973) 0.75
The nature of the ribonucleic acid synthetized in vitro by Sendai virus-induced ribonucleic acid-dependent ribonucleic acid polymerase. J Gen Microbiol (1970) 0.75
Studies on the nature of influenza virus ribonucleic acid. J Gen Microbiol (1970) 0.75
Hybrid plasmids carrying part of the Rous sarcoma virus-specific leader sequence. Biochim Biophys Acta (1981) 0.75
The replication of influenza virus RNA. J Antimicrob Chemother (1975) 0.75
In vivo metabolism of H3-medroxyprogesterone acetate in pregnant and nonpregnant women and in the fetus. Am J Obstet Gynecol (1966) 0.75
In vitro biosynthetic studies of endocrine tumors. VI. Malignant granulosa cell tumor. Am J Obstet Gynecol (1966) 0.75